Conference Coverage

ACR: New Sjögren’s classification criteria on the way


 

AT THE ACR ANNUAL MEETING

References

The National Institutes of Health, the National Institute of Dental and Craniofacial Research, the Phileona Foundation, and the Sjögren’s Syndrome Foundation helped fund the SICCA and OMRF cohort studies on which the criteria were based. Dr. Shiboski and Dr. Seror had no disclosures. Dr. Baer reported having been a consultant for Bristol-Myers Squibb and Glenmark Pharmaceuticals.

* Correction, 11/17/15: Dr. Shiboski's gender was previously misstated.

Pages

Recommended Reading

EULAR: Panel targets six rheumatic disease comorbidities
MDedge Internal Medicine
New IPF guidelines limit treatment choices
MDedge Internal Medicine
First-line ambrisentan plus tadalafil halved PAH events
MDedge Internal Medicine
Tabalumab development for lupus stops because of mixed phase III results
MDedge Internal Medicine
VIDEO: Don’t rely on ANCA to diagnose primary vasculitis
MDedge Internal Medicine
VIDEO: Simple skin finding differentiates diffuse scleroderma from limited disease
MDedge Internal Medicine
VIDEO: How to handle pregnancy in lupus
MDedge Internal Medicine
Skip vasoreactivity testing in connective tissue disease PAH work-up
MDedge Internal Medicine
VIDEO: MMF equals cyclophosphamide’s efficacy in sclerodermal lung disease
MDedge Internal Medicine
Lupus and diffuse large B-cell lymphoma share genetic risk
MDedge Internal Medicine

Related Articles